x
We use our own and third-party cookies to improve our services. If you continue browsing, we assume that you accept its use.
Information about cookiesAccept cookiesDecline cookies
GP Pharm believes in research and people. We bring science to the Society.
We invest in the latest technologies for continuous innovation.
We develop pharmaceutical products from laboratory to market.
GP Pharm: continuously growing and expanding our worldwide presence.

About us

GP Pharm is a private Spanish biopharmaceutical firm located in Barcelona area founded in 2000. It is specialized in products for injection mostly within the fields of Oncology and Urology using technological platforms based on Microspheres and Liposomes. The company is working in the complete development of these drugs starting from R&D, pre-clinical and clinical studies and registration until the launch to the market. GP Pharm develops drug delivery formulations for its own and for third parties.

The company´s business model is based on four different areas, i.e. R&D, Contract Manufacturing and Contract Development (CDMO), Licensing In & Out and Commercialization. This is affordable by a continuous investment in research and innovative technologies and a wide experienced team of employees most of which are highly trained and possess a bachelor, master or PhD. In addition, GP Pharm’s state of art manufacturing facilities have been widely approved by different Regulatory Agencies –including EU, US or Japan– allowing the firm to be position in a worldwide setting.

For the commercialization of its products, our firm built up its own commercial structure in Spain and collaborations with well-established international pharmaceutical companies, in order to promote and distribute its portfolio products with licensing and supply agreements. In addition, our enterprise is always open to discuss co-development of its clinical projects in advanced stages.

GP Pharm exploits its broad experience in pharmaceutical product development as well as its modern manufacturing facilities to offer Contract Manufacturing and Contract Development services to third parties.

Highlights

Bootstrap Thumbnail First

euroPLX

February 25-26, 2019

GP Pharm will be present in the 69th euroPLX that will take place in London in February. euroPLX is one of the world's most important business development platform, which attracts CEOs, owners of medium-sized drug producers, vice presidents, directors and managers with decision power, among others.

Bootstrap Thumbnail First

BIO-Europe Spring

March 25-27, 2019

GP Pharm will be present in the 13th Annual International Partnering Conference (BIO-EUROPE SPRING) which will take place in Vienna, Austria. BIO-Europe Spring attracts a wide range of business leaders, including senior executives of leading biotech companies, business development teams from large and midsize pharmaceutical companies, investors and other industry experts.

Bootstrap Thumbnail First

BIO International Convention

June 3-6, 2019

GP Pharm will be present in the BIO International Convention which will take place in Philadelphia. The BIO International Convention attracts over 16,000 biotechnology and pharma leaders who come together for one week of intensive networking to discover new opportunities and promising partnerships.

Back to Top